FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 53 filers reported holding FENNEC PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26 | -18.8% | 3,460 | -4.8% | 0.00% | – |
| Q2 2023 | $32 | -60.5% | 3,635 | -62.5% | 0.00% | – |
| Q1 2023 | $81 | -9.0% | 9,697 | +4.7% | 0.00% | – |
| Q4 2022 | $89 | -99.6% | 9,260 | +249.7% | 0.00% | – |
| Q3 2021 | $25,000 | +19.0% | 2,648 | -11.6% | 0.00% | – |
| Q2 2021 | $21,000 | -81.4% | 2,994 | -83.5% | 0.00% | – |
| Q1 2021 | $113,000 | +113.2% | 18,194 | +159.0% | 0.00% | – |
| Q4 2020 | $53,000 | -11.7% | 7,024 | -28.3% | 0.00% | – |
| Q3 2020 | $60,000 | -40.0% | 9,803 | -18.1% | 0.00% | – |
| Q2 2020 | $100,000 | +4900.0% | 11,965 | +2103.5% | 0.00% | – |
| Q2 2019 | $2,000 | -88.2% | 543 | -84.1% | 0.00% | – |
| Q1 2019 | $17,000 | -55.3% | 3,416 | -26.2% | 0.00% | – |
| Q3 2018 | $38,000 | +375.0% | 4,631 | +458.0% | 0.00% | – |
| Q2 2018 | $8,000 | – | 830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
| Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
| DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
| HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
| AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
| Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
| Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
| Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
| 683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |